CN106038592A - Compound for preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof - Google Patents

Compound for preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof Download PDF

Info

Publication number
CN106038592A
CN106038592A CN201610503154.1A CN201610503154A CN106038592A CN 106038592 A CN106038592 A CN 106038592A CN 201610503154 A CN201610503154 A CN 201610503154A CN 106038592 A CN106038592 A CN 106038592A
Authority
CN
China
Prior art keywords
fructus
water
liquid
cardiovascular
processing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610503154.1A
Other languages
Chinese (zh)
Inventor
李仁山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610503154.1A priority Critical patent/CN106038592A/en
Publication of CN106038592A publication Critical patent/CN106038592A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a compound for preventing and treating cardiovascular and cerebrovascular diseases and a preparation method thereof. The compound comprises a main functional solution A, a first auxiliary solution B and a second auxiliary solution C, wherein the main functional solution A comprises 14-24% of filling agents, 13-18% of acid substance agents and 67-73% of micro-molecular activated water; the first auxiliary solution B comprises 260mu/g SOD active enzyme, vitamins A, C, D, E B1, B2, B6 and B12 with total content of 170-260mg/g and 160mu g/mL amino acid; and the second auxiliary solution C comprises 100% of micro-molecular activated water. According to the invention, scaling static plugs in blood vessels can be effectively separated; the compound can be effectively attached to the inner wall through the protective membrane of the blood vessels; the compound is capable of diminishing inflammation and sterilizing, repairing the damaged blood vessel wall, recovering the elasticity of the blood vessels and keeping the microcirculation of the arteries, veins and blood capillaries unblocked and smooth; and the compound can prevent the blood vessels from hardening and aging.

Description

A kind of compositions of prevention and treatment cardiovascular and cerebrovascular disease and preparation method thereof
Technical field
The present invention is compositions of a kind of prevention and treatment cardiovascular and cerebrovascular disease and preparation method thereof.
Background technology
Cardiovascular and cerebrovascular disease is surprisingly the commonly encountered diseases that a kind of serious threat mankind particularly middle-aged and elderly people is healthy, though application Most advanced, perfect treatment means, still can have the cerebrovas-cularaccident survivor life of more than 50% not take care of oneself completely.The heart Cerebrovascular disease has " sickness rate is high, mortality rate is high, disability rate is high, relapse rate is high, the feature of complication many " four is high by more than ", At present, China's Patients with Cardiovascular/Cerebrovascular Diseases alreadys more than 2.7 hundred million people, and sickness rate is more and more higher, and becomes rejuvenation development, heart and brain blood Pipe disease is the number one killer of human health, is classified as one of current full scope of organization overall work emphasis by World Health Organization (WHO)！
People once obtained cardiovascular and cerebrovascular disease, general embodiment by: (1.) patient can only take what doctor was opened all the life Suppression class, controls class cardiovascular and cerebrovascular vessel chemical classes medicine and takes for a long time eventually, and side effect is very big, and impairing the liver is impairment of the kidney, imapirment of the spleen and stomach, causes again Drug-induced disease, has a pathological changes how sick, and many pathological changes severe disease finally pasts medical help, and (2) do cardiac stent, bypass surgery, also to take With expensive thrombolytic agent, extremely inconvenience, to oneself causing great misery, to family, society brings huge economic damage Become estranged burden.Trace it to its cause and be because modern medicine and the most do not look for and see and cause hypertension, coronary heart disease, apoplexy, myocardial infarction, vascular The scorching real cause of disease.
" the most bitterly, pain is the most obstructed for the general rule " medicine principle proposed according to ming dynasty of china well-known doctor's Li Shizhen (1518-1593 A.D.), causes cardiovascular and cerebrovascular vessel The reason of disease, finds mainly to have the reason of three aspects:
1, one of mankind's cardiovascular and cerebrovascular disease reason is caused: the quality being exactly the blood, blood trickled in human body is bad, The critically important reason that the quality of blood is bad is that the water quality in blood is out of joint, (a) along with the industrialized development of modern society, We increasingly deteriorate by the environment of life, and air is contaminated, and a large amount of of fertilizer and pesticide use soil to be contaminated, and add work A large amount of discharges of industry waste water, underground water source is also contaminated, and the tap water drunk every day including us is also heavy metal, and chlorine has waited Pest matter exceeds standard, the quality affecting our blood serious after entering human body；(b) qi depression to blood stasis, the mankind of modern society, competing Striving more and more fierce, the pressure of life is increasing, the emotion extremely unstable of people, can not get recuperation and rests in peace, is in nerve all the time , there is rage in nervous tight state, it is easy to mood goes wrong, gives birth to air, depressed, gloomy, manic etc., causes the heart, liver, spleen The silting of internal organs organ blood capillary and obstructed, do not processed for a long time, mood pent-up increasingly severe, organ capillary in the past The silting of blood vessel also gets more and more, the rubbish in blood, metabolite, free radical, and cholesterol etc. is the most cumulative can not be arranged in time Going out external, the blood souring causing blocked organ blood vessel is fouled, and the also souring of the water quality in blood is fouled, in blood Oxygen carrying content is more and more not enough, and the flow velocity of blood flow the most more comes slowly, causes heart, blood supply insufficiency of brain, sensation of oppression over the chest with shortness of breath, has a dizzy spell, The blood souring of blocked organ blood vessel is fouled and is caused again blocked organ and blood vessel generation pathological changes, and causes other internal organs Organ blood blood supply insufficiency, causes the pathological changes of other internal organs organ.So wanting health, beautiful, long-lived, first have to change blood Quality, particular importance is intended to drink water, rich in mineral substances energy water, activated water, healthy water, also needs to adjust simultaneously Phychology and science food meal, appropriate exercise.
2, in water and vegetable, the binding agent carbon that the calcium bicarbonate contained in the food such as fruit generates after decomposing after entering human body Acid calcium and calcium oxalate are human metabolite (such as cholesterol, three Phyllanthus emblica L. fat, sugar crystallization etc.) and the solids bonding of entrance human body, viscous Knot is on blood vessel, organ, and fouling the most easy to stick, at blood capillary, forms tamper, i.e. forms static tamper in blood vessel wall, For myocardial infarction, the cardiovascular and cerebrovascular disease such as apoplexy leaves huge potential risk, along with the increase at age, tremulous pulse, vein, capillary In blood vessel blood vessel wall, fouling is more and more thicker, and blood vessel caliber is more and more less, so that blood flow compensates, allows cell obtain more battalion Support, heighten blood pressure；Additionally entering the lipid of blood, cholesterol, the metabolite such as three Phyllanthus emblica L. fat in blood, forms medicated porridge sample lipid speckle Block, the flowing tamper such as thrombosis, so that blood circulation is smooth, causes the rising of blood pressure, causes heart, blood supply insufficiency of brain, capillary Blood vessel microcirculation blood supply insufficiency, there is heart infarction, cerebral infarction, apoplectic hemiplegia and death in severe patient.(write " human body knot with reference to Liu Zhi core Dirt ")
3, the fouling on blood vessel makes the elasticity of blood vessel self weaken, elastic reduction, limits blood pressure and is automatically adjusted, from Got more and more by base, cause blood vessel to harden further aging.
4, along with the increase at people's age, human body intestinal canal is too many because stool is detained, and causes people's relieving constipation the most smooth, it is impossible in time by people The metabolite that body produces excretes, and the souring that stays in the body on the contrary is fouled, and becomes toxin, has influence on the quality of blood in turn, Also the health of the vital organs of the human body is affected.
On the whole, " life-span " of people depends on the life-span of blood vessel and blood, and the life-span of blood vessel depends on In the quality of blood, the healthy quality of blood depends on: (1). vascular canal unblocked；(2). vascular canal wall smooth With blood vessel high resilience；(3). the water quality entering blood is that needed by human body wants rich in mineral substances trace element to tie with similar cell The activated water of structure, is effectively increased water and intercellular communication efficiency, blood circulation promoting, directly improves the quality of blood；(4). Removing the oxygen-derived free radicals in blood in time stops it to form the flowing tamper in blood vessel；(5) spleen, stomach, the health of intestinal, i.e. protect Card the foundation of acquired constitution hemopoietic, hemopoietic, alimentation is normal and drain passage unimpeded.
Summary of the invention
It is an object of the invention to provide a kind of can effective a kind of prevention and treatment cardiovascular and cerebrovascular disease compositions and Preparation method.
For achieving the above object, the present invention is by the following technical solutions:
A kind of prevention and the compositions for the treatment of cardiovascular and cerebrovascular disease, including: function of tonic chord liquid A, the first auxiliary liquid B and the second auxiliary liquid The ratio of the mass percent of C, described function of tonic chord liquid A, the first auxiliary liquid B and the second auxiliary liquid C is: 68-75:15-18:7-17.
Further, described function of tonic chord liquid A includes:
Filler 14-24%；
Acid substance agent 13-18%；
Activation of small molecule water 67-73%；
Said components summation is 100%.
Further, described filler includes:
Vitamin liquid includes one or more in A, C, D, E, B1, B2, B6, B12, and total content 110-140mg/g is described Mineral liquid contains: ferrum 0.016～0.019 (mg/L), zinc 0.003～0.005 (mg/L), manganese 0.006～0.008 (mg/L), cobalt 0.006～0.008 (mg/L), chromium 0.015～0.019 (mg/L), selenium 0.010～0.012 (mg/L)；Ammonia in described aminoacids solution Base acid content is 230ug/mL, and described small molecular sugar is sucrose.
Further, described acid substance agent is ph value 3.5 5.5, and the medical hydrochloric acid containing HCl9.5% 10.5% is water-soluble Liquid.
Further, described first auxiliary liquid B includes: SOD organized enzyme 260u/g, vitamin A, C, D, E, B1, B2, B6, B12, total content 170-260mg/g, amino acid/11 60ug/mL.
Further, described second auxiliary liquid C includes: activation of small molecule water 100%.
The preparation method of the compositions of a kind of prevention and treatment cardiovascular and cerebrovascular disease, described method is used for preparing function of tonic chord liquid A, the first auxiliary liquid B and the second auxiliary liquid C, the preparation method of function of tonic chord liquid A is:
Step one: spring water is carried out coarse filtration；
Step 2: the water after processing in step one filters through activated carbon；
Step 3: the water after processing in step 2 is through 5um secondary filter；
Step 4: the water after processing in step 3 is through 1um secondary filter；
Step 5: the water after processing in step 4 filters through doughnut ultraprecise and imports in surge tank standby With；
Step 6: the water after step 5 being processed imports in aseptic blender, adds filler, described filler and water Ratio be 14-24:67-73, described filler includes:
Aminoacids solution 20-32%；
Vitamin liquid 43-57%；
Small molecular sugar 17-39%；
Said components summation is 100%；
Wherein vitamin liquid includes one or more in A, C, D, E, B1, B2, B6, B12, total content 110-140mg/g, In described aminoacids solution, amino acid content is 230ug/mL, and described small molecular sugar is sucrose；
Step 7: by acid substance agent i.e. ph value 3.5 5.5, the medical aqueous hydrochloric acid solution containing HCl9.5% 10.5% enters Row 37～40MHz nuclear magnetic resonance, NMR processes, and applies the process of 25kHz ultrasonic wave concussion simultaneously, continues 20 minutes；
Step 8: the acid substance agent after processing in step 7 joins in the mixed liquor after processing in step 6, carries out 37～40 nuclear magnetic resonance, NMR, and apply the process of 25kHz ultrasonic wave concussion simultaneously, stand 5 minutes after continuing 10 minutes, then carry out 30MHz nuclear magnetic resonance, NMR, and apply the process of 25kHz ultrasonic wave concussion simultaneously, continue 5 minutes, described acid substance agent and the ratio of water For 13-18:67-73；
Step 9: the mixed liquor ozone sterilization after step 8 is processed, ultraviolet sterilization, fill, sealing, secondary ultraviolet After germicidal irradiation, warehouse-in stores.
Further, the preparation method of described first auxiliary liquid B is:
Step 1: by Radix Dauci Sativae, Fructus Litchi, Fructus Mali pumilae, Fructus Vitis viniferae, Folium Camelliae sinensis, Fructus Citri junoris, Fructus Mangifera Indicae, Fructus Hippophae, Fructus Crataegi, Fructus actinidiae chinensis, Fructus Lycii, Mulberry Shen, Herba Crotalariae sessiliflorae, Brassica oleracea L.var.capitata L., Herba Apii graveolentis, Citrullus vulgaris, Bulbus Allii Fructus Rosae Normalis, Bulbus Allii, Fructus Cucumidis sativi clean chopping, wherein Radix Dauci Sativae 15-20 part, Fructus Litchi 20-25 part, Fructus Mali pumilae 10-15 part, Fructus Vitis viniferae 15-20 part, Folium Camelliae sinensis 3-5 part, Fructus Citri junoris 10-15 part, Fructus Mangifera Indicae 15-20, Fructus Hippophae 3-5 part, mountain Short, bristly hair or beard 5-10 part, Fructus actinidiae chinensis 10-15 part, Fructus Lycii 7-10 part, Fructus Mori 5-8 part, Herba Crotalariae sessiliflorae 1-3 part, Brassica oleracea L.var.capitata L. 10-15, Herba Apii graveolentis 8-10 Part, Citrullus vulgaris 15-20 part, Bulbus Allii 1-3 part, Fructus Rosae Normalis 5-10, Fructus Cucumidis sativi 7-10 part；
Step 2: add clear water according to solid-liquid ratio 1:11-12, and be heated to 80 DEG C, filters after stirring 30min, is gone by residue Remove, leave material liquid；
Step 3: be transplanted in the material liquid of step 2 by prebiotic zymocyte, keeps 25-26 DEG C of fermentation 70 in oxygen-free environment My god；
Step 4: process 20min, packaging warehouse-in by carrying out 40MHz nuclear magnetic resonance, NMR after filtering fermentation liquor.
Further, the preparation method of described second auxiliary liquid C is:
Step a: spring water is carried out coarse filtration；
Step b: the water after processing in step one filters through activated carbon；
Step c: the water after processing in step 2 is through 5um secondary filter；
Step d: the water after processing in step 3 is through 1um secondary filter；
Step e: the water after processing in step 4 filters through doughnut ultraprecise and imports in surge tank standby；
Step f: step e water is carried out 37～40 nuclear magnetic resonance, NMR, and applies the process of 25kHz ultrasonic wave concussion simultaneously, continue After 20, after ozone sterilization, ultraviolet sterilization, fill, sealing, secondary UVGI, warehouse-in stores.
The present invention can efficiently separate endovascular fouling static state tamper, simultaneously can be effectively by the protecting film of blood vessel Absorption on inwall, anti-inflammation and sterilization, repair damage blood vessel wall, make blood vessel again recover the elasticity of itself, make tremulous pulse, quiet Arteries and veins, blood capillary microcirculation keeps unblocked.Prevent sclerosis of blood vessels aging.
Detailed description of the invention
In order to make the purpose of the present invention, technical scheme and advantage clearer, below in conjunction with embodiment, to the present invention It is explained in further detail.Should be appreciated that specific embodiment described herein is used only for explaining the present invention, be not used to Limit the present invention.
On the contrary, the present invention contain any be defined by the claims the replacement done in the spirit and scope of the present invention, repair Change, equivalent method and scheme.Further, in order to make the public that the present invention to be had a better understanding, thin to the present invention below During joint describes, detailed describe some specific detail sections.There is no these detail sections for a person skilled in the art Description can also understand the present invention completely.Below in conjunction with detailed description of the invention, the present invention is further described.
A kind of prevention and the compositions for the treatment of cardiovascular and cerebrovascular disease, including: function of tonic chord liquid A, the first auxiliary liquid B and the second auxiliary liquid The ratio of the mass percent of C, described function of tonic chord liquid A, the first auxiliary liquid B and the second auxiliary liquid C is: 68-75:15-18:7-17.
Described function of tonic chord liquid A includes:
Filler 14-24%；
Acid substance agent 13-18%；
Activation of small molecule water 67-73%；
Said components summation is 100%.
Described filler includes:
Vitamin liquid includes A, C, D, E, B1、B2、B6、B12In one or more, total content 110-140mg/g, described ore deposit Material liquid contains: ferrum 0.016～0.019 (mg/L), zinc 0.003～0.005 (mg/L), manganese 0.006～0.008 (mg/L), cobalt 0.006～0.008 (mg/L), chromium 0.015～0.019 (mg/L), selenium 0.010～0.012 (mg/L)；Ammonia in described aminoacids solution Base acid content is 230ug/mL, and described small molecular sugar is sucrose.
Described acid substance agent is ph value 3.5 5.5, the medical aqueous hydrochloric acid solution containing HCl9.5% 10.5%.
Described first auxiliary liquid B includes: SOD organized enzyme 260u/g, vitamin A, C, D, E, B1、B2、B6、B12, total content 170- 260mg/g, amino acid/11 60ug/mL.
Described second auxiliary liquid C includes: activation of small molecule water 100%.
A kind of preparation method of the compositions of prevention and treatment cardiovascular and cerebrovascular disease, the preparation method of described function of tonic chord liquid A For:
Step one: spring water is carried out coarse filtration；
Step 2: the water after processing in step one filters through activated carbon；
Step 3: the water after processing in step 2 is through 5um secondary filter；
Step 4: the water after processing in step 3 is through 1um secondary filter；
Step 5: the water after processing in step 4 filters through doughnut ultraprecise and imports in surge tank standby With；
Step 6: the water after step 5 being processed imports in aseptic blender, adds filler, described filler and water Ratio be 14-24:67-73, described filler includes:
Aminoacids solution 20-32%；
Vitamin liquid 43-57%；
Small molecular sugar 17-39%；
Said components summation is 100%.
Wherein vitamin liquid includes A, C, D, E, B1、B2、B6、B12In one or more, total content 110-140mg/g, institute Stating amino acid content in aminoacids solution is 230ug/mL, and described small molecular sugar is sucrose；
Step 7: by acid substance agent i.e. ph value 3.5 5.5, the medical aqueous hydrochloric acid solution containing HCl9.5% 10.5% enters Row 37～40MHz nuclear magnetic resonance, NMR processes, and applies the process of 25kHz ultrasonic wave concussion simultaneously, continues 20 minutes；
Step 8: the acid substance agent after processing in step 7 joins in the mixed liquor after processing in step 6, carries out 37～40 nuclear magnetic resonance, NMR, and apply the process of 25kHz ultrasonic wave concussion simultaneously, stand 5 minutes after continuing 10 minutes, then carry out 30MHz nuclear magnetic resonance, NMR, and apply the process of 25kHz ultrasonic wave concussion simultaneously, continue 5 minutes, described acid substance agent and the ratio of water For 13-18:67-73；
Step 9: the mixed liquor ozone sterilization after step 8 is processed, ultraviolet sterilization, fill, sealing, secondary ultraviolet After germicidal irradiation, warehouse-in stores.
The preparation method of described first auxiliary liquid B is:
Step 1: by Radix Dauci Sativae, Fructus Litchi, Fructus Mali pumilae, Fructus Vitis viniferae, Folium Camelliae sinensis, Fructus Citri junoris, Fructus Mangifera Indicae, Fructus Hippophae, Fructus Crataegi, Fructus actinidiae chinensis, Fructus Lycii, Mulberry Shen, Herba Crotalariae sessiliflorae, Brassica oleracea L.var.capitata L., Herba Apii graveolentis, Citrullus vulgaris, Bulbus Allii Fructus Rosae Normalis, Bulbus Allii, Fructus Cucumidis sativi clean chopping, wherein Radix Dauci Sativae 15-20 part, Fructus Litchi 20-25 part, Fructus Mali pumilae 10-15 part, Fructus Vitis viniferae 15-20 part, Folium Camelliae sinensis 3-5 part, Fructus Citri junoris 10-15 part, Fructus Mangifera Indicae 15-20, Fructus Hippophae 3-5 part, mountain Short, bristly hair or beard 5-10 part, Fructus actinidiae chinensis 10-15 part, Fructus Lycii 7-10 part, Fructus Mori 5-8 part, Herba Crotalariae sessiliflorae 1-3 part, Brassica oleracea L.var.capitata L. 10-15, Herba Apii graveolentis 8-10 Part, Citrullus vulgaris 15-20 part, Bulbus Allii 1-3 part, Fructus Rosae Normalis 5-10, Fructus Cucumidis sativi 7-10 part；
Step 2: add clear water according to solid-liquid ratio 1:11-12, and be heated to 80 DEG C, filters after stirring 30min, is gone by residue Remove, leave material liquid；
Step 3: be transplanted in the material liquid of step 2 by prebiotic zymocyte, keeps 25-26 DEG C of fermentation 70 in oxygen-free environment My god；
Step 4: process 20min, packaging warehouse-in by carrying out 40MHz nuclear magnetic resonance, NMR after filtering fermentation liquor.
The preparation method of described second auxiliary liquid C is:
Step a: spring water is carried out coarse filtration；
Step b: the water after processing in step one filters through activated carbon；
Step c: the water after processing in step 2 is through 5um secondary filter；
Step d: the water after processing in step 3 is through 1um secondary filter；
Step e: the water after processing in step 4 filters through doughnut ultraprecise and imports in surge tank standby；
Step f: step e water is carried out 37～40 nuclear magnetic resonance, NMR, and applies the process of 25kHz ultrasonic wave concussion simultaneously, continue After 20, after ozone sterilization, ultraviolet sterilization, fill, sealing, secondary UVGI, warehouse-in stores.
The present invention by multiple times of filtration nuclear magnetic resonance, NMR, ultrasonic involve heating pressurized treatments, convert the water to micromolecular water, energy Improving blood viscosity, water has energy, utilizes low-frequency characteristic, changes the structure of hydrone, becomes the cytoid knot of class Structure water, to bioinformatics conduction machine turn more easily reach regulation and control organism metabolic activity, maintain organism it Constant environment reaches healthy and oneself's treatment purpose more.Hydrone after nuclear magnetic resonance, NMR substantially broadens about 10 degree because of hydrogen bond angle For higher hydrogen bond, this energy enhancing that can make water and easier neutralization free radical, this makes tremulous pulse, flows in venous capillary In vivo, the infiltration rate of cells in vivo increases by 3 times to dynamic moisture, hence it is evident that improves the blood circulation of whole body, strengthens human body Function of detoxification, promote blood rubbish metabolism, strengthen cell absorption efficiency, oxygen carrying content increase, increased activity.
The edible hydrochloric acid of certain density Nano quantum nuclear magnetic resonance, NMR can fully dissolve, and the fouling static state in separating blood vessel is blocked up Plug thing, simultaneously can effectively by the protecting film absorption of blood vessel on inwall, anti-inflammation and sterilization, repair the blood vessel wall of damage, make blood vessel Again recovering the elasticity of itself, make tremulous pulse, vein, blood capillary microcirculation keeps unblocked.Prevent sclerosis of blood vessels aging.
First auxiliary liquid B supplements SOD organized enzyme and is combined fruit ferment, and SOD is its agent of universally acknowledged natural anti-oxidation, can have Effect has the multiple nutrients needed for born of the same parents in providing blood in human body in pipe: several amino acids, various active enzyme, protein and lot of trace are first Element, vitamin A, C, D, E, B1, B2, B6, B12, supplement the nutrients to cell in time so that it is get well, make blood vessel secure good health, Blood quality sufficiently improves.
Second auxiliary liquid C can effectively supplement mineral, improves the absorbance that compositions is overall.
(1) prevention of cardiovascular and cerebrovascular disease: 18-30 one full year of life, drinks the function of tonic chord liquid A every day and is no less than 600 milliliters, divide 3 times Drink, divided 3 times before early, middle and late 1 hour before the meal as far as possible, drink 200 milliliters every time, within 3 months, be a circulation, at 3 months It is adjusted to afterwards and drinks 400 milliliters every day, drank before point twice 1 hour before the meal morning and evening；B. more than 30-55 one full year of life, Drink the function of tonic chord liquid A every day no less than 1000 milliliters, as far as possible early, middle and late meal, sleep before 1 little time-division drink for 4 times, within 3 months, be One circulation, was adjusted to after 3 months and drinks 600 milliliters every day and drank in three times before early, middle and late 1 hour before the meal；
(2), more than .55 year, drink the function of tonic chord liquid A600 milliliter every day, drank in three times before early, middle and late 1 hour before the meal With, 4--6 month is a circulation；First auxiliary liquid B daily 15 milliliters；Mineral liquid just drinks 8 glasss (250 milliliters) every day Gradually reduce Western medicine dose between.After six months, function of tonic chord liquid A is adjusted to and drinks 1000 milliliters every day, early, middle and late Dividing before meal, evening sleeping first 1 hour and drink for 4 times, the first auxiliary liquid B drinks 25 milliliters every day after the meal；Second auxiliary liquid C drinks 8 glasss every day (250 liters) point are drunk for 4 times.Can reduce after 1 year and take Western medicine kind, after 2 years, only stay the 1--2 kind standby medicine of urgent need.
First course for the treatment of carried out more than 55 years old group to patient, carried out Ureteral Calculus, and patient drinks the function of tonic chord liquid A600 milliliter every day, Drinking for three times, early, middle and late 1 little time-division before the meal drinks for 3 times, each 200 milliliters；4--6 month every day of second course for the treatment of drinks 1000 milliliters, before sleeping in early, middle and late meal, evening, point drank the first auxiliary liquid B for 4 times before 1 hour drink 25 milliliters every day；Second is auxiliary Liquid C drinks 8 glasss (250 liters) point and drink for 4 times every day.
Its curative effect is as in the table below:

Claims (9)

1. a prevention and the compositions for the treatment of cardiovascular and cerebrovascular disease, it is characterised in that including: function of tonic chord liquid A, the first auxiliary liquid B With the ratio of the mass percent of the second auxiliary liquid C, described function of tonic chord liquid A, the first auxiliary liquid B and the second auxiliary liquid C it is: 68-75:15-18: 7-17。
Prevention the most according to claim 1 and the compositions for the treatment of cardiovascular and cerebrovascular disease, it is characterised in that
Described function of tonic chord liquid A includes:
Filler 14-24%；
Acid substance agent 13-18%；
Activation of small molecule water 67-73%；
Said components summation is 100%.
Prevention the most according to claim 2 and the compositions for the treatment of cardiovascular and cerebrovascular disease, it is characterised in that described filler Including:
Aminoacids solution 17-22%；
Mineral liquid: 12-34%
Vitamin liquid 43-50%；
Small molecular sugar 14-24%；
Said components summation is 100%；
Vitamin liquid includes A, C, D, E, B1、B2、B6、B12In one or more, total content 110-140mg/g, described mineral Liquid contains: ferrum 0.016 ~ 0.019(mg/L), zinc 0.003 ~ 0.005(mg/L), manganese 0.006 ~ 0.008(mg/L), cobalt 0.006 ~ 0.008(mg/L), chromium 0.015 ~ 0.019(mg/L), selenium 0.010 ~ 0.012(mg/L)；Amino acid content in described aminoacids solution For 230ug/mL, described small molecular sugar is sucrose.
Prevention the most according to claim 2 and the compositions for the treatment of cardiovascular and cerebrovascular disease, it is characterised in that described acid substance Agent is ph value 3.5 5.5, the medical aqueous hydrochloric acid solution containing HCl9.5% 10.5%.
Prevention the most according to claim 1 and the compositions for the treatment of cardiovascular and cerebrovascular disease, it is characterised in that described first auxiliary Liquid B includes: SOD organized enzyme 260u/g, vitamin A, C, D, E, B1、B2、B6、B12, total content 170-260mg/g, aminoacid 160ug/mL。
Prevention the most according to claim 1 and the compositions for the treatment of cardiovascular and cerebrovascular disease, it is characterised in that described second auxiliary Liquid C includes: activation of small molecule water 100%.
7. prevention and the preparation method of compositions for treatment cardiovascular and cerebrovascular disease, described method be used for preparing function of tonic chord liquid A, First auxiliary liquid B and the second auxiliary liquid C, it is characterised in that the preparation method of function of tonic chord liquid A is:
Step one: spring water is carried out coarse filtration；
Step 2: the water after processing in step one filters through activated carbon；
Step 3: the water after processing in step 2 is through 5um secondary filter；
Step 4: the water after processing in step 3 is through 1um secondary filter；
Step 5: the water after processing in step 4 filters through doughnut ultraprecise and imports in surge tank standby；
Step 6: the water after step 5 being processed imports in aseptic blender, adds filler, described filler and the ratio of water Example is 14-24:67-73, and described filler includes:
Aminoacids solution 20-32%；
Vitamin liquid 43-57%；
Small molecular sugar 17-39%；
Said components summation is 100%；
Wherein vitamin liquid includes A, C, D, E, B1、B2、B6、B12In one or more, total content 110-140mg/g, described ammonia In base acid solution, amino acid content is 230ug/mL, and described small molecular sugar is sucrose；
Step 7: by acid substance agent i.e. ph value 3.5 5.5, the medical aqueous hydrochloric acid solution containing HCl9.5% 10.5% carries out 37 ~ 40MHz nuclear magnetic resonance, NMR processes, and applies the process of 25kHz ultrasonic wave concussion simultaneously, continues 20 minutes；
Step 8: the acid substance agent after processing in step 7 joins in the mixed liquor after processing in step 6, carries out 37 ~ 40 Nuclear magnetic resonance, NMR, and apply the process of 25kHz ultrasonic wave concussion simultaneously, stand 5 minutes after continuing 10 minutes, then carry out 30MHz core Magnetic resonance, and apply the process of 25kHz ultrasonic wave concussion simultaneously, continuing 5 minutes, described acid substance agent is 13-18 with the ratio of water: 67-73；
Step 9: the mixed liquor ozone sterilization after step 8 is processed, ultraviolet sterilization, fill, sealing, secondary ultraviolet sterilization After irradiation, warehouse-in stores.
The preparation method of the compositions of prevention the most according to claim 7 and treatment cardiovascular and cerebrovascular disease, it is characterised in that The preparation method of described first auxiliary liquid B is:
Step 1: by Radix Dauci Sativae, Fructus Litchi, Fructus Mali pumilae, Fructus Vitis viniferae, Folium Camelliae sinensis, Fructus Citri junoris, Fructus Mangifera Indicae, Fructus Hippophae, Fructus Crataegi, Fructus actinidiae chinensis, Fructus Lycii, Fructus Mori, open country Bulbus Lilii, Brassica oleracea L.var.capitata L., Herba Apii graveolentis, Citrullus vulgaris, Bulbus Allii Fructus Rosae Normalis, Bulbus Allii, Fructus Cucumidis sativi clean chopping, wherein Radix Dauci Sativae 15-20 part, Fructus Litchi 20-25 Part, Fructus Mali pumilae 10-15 part, Fructus Vitis viniferae 15-20 part, Folium Camelliae sinensis 3-5 part, Fructus Citri junoris 10-15 part, Fructus Mangifera Indicae 15-20, Fructus Hippophae 3-5 part, Fructus Crataegi 5-10 Part, Fructus actinidiae chinensis 10-15 part, Fructus Lycii 7-10 part, Fructus Mori 5-8 part, Herba Crotalariae sessiliflorae 1-3 part, Brassica oleracea L.var.capitata L. 10-15, Herba Apii graveolentis 8-10 part, Citrullus vulgaris 15-20 part, Bulbus Allii 1-3 part, Fructus Rosae Normalis 5-10, Fructus Cucumidis sativi 7-10 part；
Step 2: add clear water according to solid-liquid ratio 1:11-12, and be heated to 80 DEG C, filters after stirring 30min, is removed by residue, Leave material liquid；
Step 3: be transplanted in the material liquid of step 2 by prebiotic zymocyte, keeps 25-26 DEG C in oxygen-free environment and ferments 70 days；
Step 4: process 20min, packaging warehouse-in by carrying out 40MHz nuclear magnetic resonance, NMR after filtering fermentation liquor.
The preparation method of the compositions of prevention the most according to claim 7 and treatment cardiovascular and cerebrovascular disease, it is characterised in that The preparation method of described second auxiliary liquid C is:
Step a: spring water is carried out coarse filtration；
Step b: the water after processing in step one filters through activated carbon；
Step c: the water after processing in step 2 is through 5um secondary filter；
Step d: the water after processing in step 3 is through 1um secondary filter；
Step e: the water after processing in step 4 filters through doughnut ultraprecise and imports in surge tank standby；
Step f: step e water is carried out 37 ~ 40 nuclear magnetic resonance, NMR, and applies the process of 25kHz ultrasonic wave concussion simultaneously, continue 20 minutes After rear ozone sterilization, ultraviolet sterilization, fill, sealing, secondary UVGI, warehouse-in stores.
CN201610503154.1A 2016-06-29 2016-06-29 Compound for preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof Pending CN106038592A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610503154.1A CN106038592A (en) 2016-06-29 2016-06-29 Compound for preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610503154.1A CN106038592A (en) 2016-06-29 2016-06-29 Compound for preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof

Publications (1)

Publication Number Publication Date
CN106038592A true CN106038592A (en) 2016-10-26

Family

ID=57201359

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610503154.1A Pending CN106038592A (en) 2016-06-29 2016-06-29 Compound for preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof

Country Status (1)

Country Link
CN (1) CN106038592A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110577937A (en) * 2019-10-22 2019-12-17 郑州奇化酶生物科技有限公司 SOD complex enzyme for removing freckles and beautifying skin and preparation method thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1159615A (en) * 1966-05-16 1969-07-30 Vivonex Corp A Nutritionally Adequate, Non-Residual Dietary Composition for the reduction of the Intestinal Microflora Level
CN101234123A (en) * 2008-02-02 2008-08-06 王德寿 Application of certain concentration hydrochloric acid water for treating blood vessel disease
CN102452758A (en) * 2010-10-14 2012-05-16 彭易勋 Production process flow of low hertz (HZ) water
CN102488455A (en) * 2011-12-23 2012-06-13 广东恒联食品机械有限公司 Water boiling device
CN104045121A (en) * 2013-03-15 2014-09-17 常州金赛肿瘤医药科技有限公司 Preparation and application methods of micromolecular water
CN105029603A (en) * 2015-06-24 2015-11-11 陈琳仁 Composite fresh flower, fruit, vegetable and herb enzyme, and preparation method and application thereof
CN105105134A (en) * 2015-09-24 2015-12-02 上海韬鸿化工科技有限公司 Blueberry enzyme and preparation method thereof
CN105152452A (en) * 2015-09-29 2015-12-16 孝感鼎盛生态农业科技有限公司 Micromolecule water production method

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1159615A (en) * 1966-05-16 1969-07-30 Vivonex Corp A Nutritionally Adequate, Non-Residual Dietary Composition for the reduction of the Intestinal Microflora Level
CN101234123A (en) * 2008-02-02 2008-08-06 王德寿 Application of certain concentration hydrochloric acid water for treating blood vessel disease
CN102452758A (en) * 2010-10-14 2012-05-16 彭易勋 Production process flow of low hertz (HZ) water
CN102488455A (en) * 2011-12-23 2012-06-13 广东恒联食品机械有限公司 Water boiling device
CN104045121A (en) * 2013-03-15 2014-09-17 常州金赛肿瘤医药科技有限公司 Preparation and application methods of micromolecular water
CN105029603A (en) * 2015-06-24 2015-11-11 陈琳仁 Composite fresh flower, fruit, vegetable and herb enzyme, and preparation method and application thereof
CN105105134A (en) * 2015-09-24 2015-12-02 上海韬鸿化工科技有限公司 Blueberry enzyme and preparation method thereof
CN105152452A (en) * 2015-09-29 2015-12-16 孝感鼎盛生态农业科技有限公司 Micromolecule water production method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
文爽: "饮水机式核磁共振活性频谱水保健仪", 《投资与营销》 *
李家泰，等: "《临床药理学》", 31 May 1991, 人民卫生出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110577937A (en) * 2019-10-22 2019-12-17 郑州奇化酶生物科技有限公司 SOD complex enzyme for removing freckles and beautifying skin and preparation method thereof

Similar Documents

Publication Publication Date Title
CN106214989A (en) A kind of defying age, the deer's blood health-care medicated wine improving memory and preparation method thereof
US8715650B2 (en) Bathing composition and method for preparing same
CN103610200A (en) Anticancer health-care oral liquid and preparation method thereof
CN105146609A (en) Lipid-lowering intestine-moistening vinegar drink and preparation method thereof
CN1058893C (en) Medicine for treating woman's dysmenorrhea and preparing process thereof
CN101468152A (en) Chinese medicine foot-bathing agent for treating hypertension and technique for preparing the same
CN106038592A (en) Compound for preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof
CN101307279A (en) Nourishing cordial and method for preparing same
CN104147053A (en) Oral liquid of traditional Uygur medicine named Kulumuti, and preparation method thereof
CN106109866B (en) It is a kind of to be used to alleviate oral liquid of dysmenorrhoea and preparation method thereof
CN1308016C (en) Enriching supplementation wine
CN104906305A (en) Hypertension drug-food nano-element drink
CN103495108B (en) Medicine for treating chronic hypotension and preparation method for medicine
CN106036269A (en) Drink containing pumpkin enzymes and preparation method thereof
CN108159191B (en) Composition for tonifying yang and invigorating kidney, application and oral liquid and preparation method thereof
CN110731508A (en) Preparation method of traditional Chinese medicine food for enhancing human immunity and product
CN103751742A (en) Preparation method of traditional Chinese medicine for treating wind-cold-headache-type hyperlipemia
CN107593968A (en) A kind of teabag drink
CN108403983A (en) Treat the stagnation resolvation Cyclandelate of cerebral infarction sequela
CN107789503A (en) A kind of oral products and preparation method for cerebral concussion and its sequelae
CN118236322B (en) Oral liquid for preventing and treating gout and preparation method thereof
CN106421028A (en) Traditional Chinese medicinal composition for preventing exercise induced fatigue, and preparation method thereof
CN105079284A (en) Chinese patent drug for treating hypertension, and preparation method thereof
CN105861225A (en) Fruity dendrobium nobile wine and preparation method thereof
CN105147865A (en) Chinese patent medicine for treating hypertension and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20161026

RJ01 Rejection of invention patent application after publication